麻豆女优

The Health 202

A State-Sanctioned Hospital Monopoly Raises Concerns

罢丑别听Federal Trade Commission聽has long argued that competition makes the economy better. But some states have stopped the agency from blocking hospital mergers that create local or regional monopolies, and the results have been messy.

Two dozen states have at some point passed controversial legislation waiving anti-monopoly laws, allowing rival hospitals to merge and replacing competition with prolonged state oversight.

Six years ago, Tennessee and Virginia ushered in the largest state-sanctioned hospital monopoly in the nation with the creation of聽Ballad Health. For most of the聽1.1 million聽residents in the Tri-Cities region of northeast Tennessee and southwest Virginia, the merged system became the only option for hospital care.

The argument for Ballad was that two hospital companies couldn鈥檛 survive in the region, and a merger would prevent them from closing or being bought up. But critics say fears a monopoly would jeopardize access to and quality of care have been realized.聽For example, since the merger, patients聽spend three times as long in Ballad emergency rooms聽before admission to hospitals, according to reports released by the Tennessee health department.

鈥淚 do not want to further risk my life and die at a Ballad hospital,鈥 said聽Neal Osborne, a city council member in Bristol, Va. In an interview, Osborne said he spent 30 hours in a Ballad ER this year as he suffered diabetic crisis. 鈥淭he wait times just to get in and see a doctor in the ER have grown exponentially.鈥

The legislation that created Ballad is known as a certificate of public advantage, or COPA. The FTC has repeatedly warned states to be wary of COPAs, which 鈥渙nly exist to protect a merger that would otherwise be illegal under antitrust law,鈥澛Rahul Rao, a deputy director of the聽Bureau of Competition聽at the agency, told 麻豆女优 Health News in an interview last year.

There have been about聽10 hospital mergers聽in the past three decades that depended on COPAs, and afterward, the feds saw rising prices, decreases in quality, reductions in access and a decrease in wages, Rao said.

Since Ballad鈥檚 COPA, the merged system has聽not met most quality-of-care goals聽set by the states in recent years. It has fallen short of charity care promises made to Tennessee by about聽$191 million聽over a five-year span.聽

Ballad has attributed its quality struggles to the coronavirus pandemic, its charity shortfalls to Medicaid changes and its longer ER stays to staffing and discharge challenges it says are beyond its control.

Ballad said ER times for admitted patients have dropped to about聽7.5 hours聽since its latest annual report. 聽

鈥淥n those issues Ballad Health can directly control, our performance has rebounded from 2022,鈥 said a Ballad spokesperson,聽Molly Luton.

The FTC announced in 2019 that it would study the Ballad merger but has yet to issue a report.

Legislation was introduced this year to limit COPAs in Tennessee. But on Tuesday, a state legislative subcommittee聽聽without debate, refusing to hear testimony from Tri-Cities residents who drove five hours to Nashville for a chance to speak against Ballad.


This article is not available for syndication due to republishing restrictions. If you have questions about the availability of this or other content for republication, please contact NewsWeb@kff.org.


Exit mobile version